Here is an article about the success of a New York medical doctor just doing his job.
Over the past month, we’ve been telling you about Dr. Zelenko, a board-certified family practitioner in New York, after he first announced that he had treated 350 coronavirus patients with 100% success using a cocktail of hydroxychloroquine, Zinc Sulfate and Azithromycin. Dr. Zelenko went on to treat 700 coronavirus patients treated with 99.9% success rate using Hydroxychloroquine, with 1 outpatient died after not following protocol. The last time we wrote about Dr. Zelenko was on April 5 after he reported in an interview that he had treated 900 coronavirus patients with 99.99% rate. We checked back to see if Dr. Zelenko is making progress with his COVID-19 patients. In his latest interview with Dr. Dennis of Prague University, Dr. Zelenko said he has now treated over 1,450 coronavirus patients with only two deaths. Calling hydroxychloroquine a potential game-changer, Dr. Zelenko maintained that his approach is to provide treatment to patients before their situation get worse so they don’t have to be admitted into the hospital and so that they don’t have to be put on ventilators. His out-patient treatment regimen, which costs only $12, is as follows:https://techstartups.com/2020/04/21/dr-vladimir-zelenko-now-treated-1450-coronavirus-patients-2-deaths-using-hydroxychloroquine-99-99-success-rate-latest-video-interview/
- Hydroxychloroquine 200mg twice a day for 5 days
- Azithromycin 500mg once a day for 5 days
- Zinc sulfate 220mg once a day for 5 days
The first YouTube video reporting his success now shows this message:
Fortunately there are still other older videos that are available of him discussing his success.
Snopes conclusion that Dr. Zelenko’s claim is unproven and cites public health officials that believe it is unsafe, but they ignore the fact that even the NIH concluded that Chloroquine would be an effective and safe option to use against the first modern coronavirus (SARS) that came on the scene in the early 2000s.
Chloroquine, a relatively safe, effective and cheap drug used for treating many human diseases including malaria, amoebiosis and human immunodeficiency virus is effective in inhibiting the infection and spread of SARS CoV in cell culture. The fact that the drug has significant inhibitory antiviral effect when the susceptible cells were treated either prior to or after infection suggests a possible prophylactic and therapeutic use.